PLYMOUTH, Minn., USA & ECOUEN, France–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces an
agreement with Vygon to distribute the SecurAcath Subcutaneous Catheter
Securement Device in France.
“As we continue to expand global distribution, we are very excited to be
able to enter the French market with Vygon as a partner,” commented Joe
Goldberger, President and CEO of Interrad Medical.
Thomas Walter, Vice President Vygon Intravascular Therapies Business
Unit stated, “We are pleased to be able to commercialize the SecurAcath
in France. The SecurAcath is a perfect fit with the Vygon portfolio of
products and we anticipate it will become the market leading catheter
The SecurAcath is the only subcutaneous catheter securement device that
lasts the life of the line and can dramatically decrease catheter
dislodgement and migration, decrease catheter replacement costs, prevent
therapy interruption, reduce catheter-related infections and other
complications, and lower total cost of patient care.
About Interrad Medical, Inc.
Plymouth, Minnesota-based Interrad Medical, Inc. is a developer,
manufacturer and marketer of medical devices designed for
minimally-invasive interventional and surgical procedures. Learn more at www.securacath.com
About Vygon Group
Vygon designs, manufactures and markets high-tech single-use medical
devices for healthcare professionals in hospital and for private and
independent practitioners. Vygon is a world leader within this industry,
offering a wide range of products in a number of clinical specialties.
Organized in five business units (Intensive Care – Neonatology, Enteral
& Obstetrics – Intravascular Therapies – Cardiovascular & Surgery –
Anesthesia & Emergency), Vygon combines local and international in-depth
expertise and know-how in each individual field. With expertise right
along the value chain, from product design to the delivery of training
for medical personnel, Vygon provides health care professionals with
effective and innovative products tailored to their needs and those of
their patients, for optimum use and safety. The company distributes over
205 million products a year in more than 120 countries through its
network of 27 subsidiaries and 331 distributors. Vygon products display
the CE and/or FDA mark and are manufactured in the group’s eight
factories in Europe, the USA and Colombia. A family company founded in
1962, Vygon is based in Ecouen, in France’s Greater Paris region. It is
a mid-sized business employing 2,350 staff worldwide. The turnover in
2017 was €310 million ($362M), with 81% of this derived from Vygon’s
international business. www.vygon.com
This press release contains forward-looking statements. The Company
wishes to caution the reader of this press release that actual results
may differ from those discussed in the forward-looking statements and
may be adversely affected by, among other things, risks associated with
litigation, clinical trials, the regulatory approval process,
reimbursement policies and commercialization of new technologies.
Interrad Medical, Inc.
Jeff Killion, 763-225-6699